| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vera Therapeutics, Inc. | 10%+ Owner | Class A Common Stock | 1,714,285 | $30,857,130 | $18.00 | 06 Feb 2023 | Held by Longitude Prime Fund, L.P. |
| Sierra Oncology, Inc. | 10%+ Owner | Common Stock | 175,000 | $9,625,000 | $55.00 | 31 Jan 2022 | Indirect |
| RAPID MICRO BIOSYSTEMS, INC. | 10%+ Owner | Class A Common Stock | 150,000 | $148,410 | $0.9894 | 19 Jul 2021 | Held by Longitude Prime Fund, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | 06 Feb 2023 | 0 | $0 | 3 | 10%+ Owner | 08 Feb 2023, 18:21 |
| /report/000089924322004269-longitude-prime-partners-llc-2022-01-31 | Sierra Oncology, Inc. | 31 Jan 2022 | 0 | $0 | 3 | 10%+ Owner | 02 Feb 2022, 20:22 |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | 19 Jul 2021 | 0 | $0 | 3 | 10%+ Owner | 20 Jul 2021, 21:32 |